publication date: Sep. 13, 2019
Why CAR-T policymaking is broken, and why we need to fix it
Vice president and
chief innovation officer,
Chief clinical officer and
senior vice president, ADVI Health
Former director of the Coverage and Analysis Group (CAG), Centers for Medicare and Medicaid Services
Chief executive officer,
The initial reports of the near-miraculous benefits of CAR-T in pediatric acute lymphoblastic leukemia generated tremendous excitement—there was a Lazarus-like quality to these stories.
The occasional serious toxicity did give some pause, but there seemed to be a solution to this scary toxicity profile as physicians learned to care for these patients. And with the clinical reports … Continue reading Why CAR-T policymaking is broken, and why we need to fix it
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.